PC-786: Clinical Trials

2 trials of PC-786, newest first

ClinicalTrials Daily  ·  Areas  ·  Conditions  ·  Drugs  ·  Sponsors  ·  

1 completed, 1 terminated. 2 Phase 2, 1 Phase 1.

By phase and status

PhaseTrialsStatus
Phase 22Completed 1, Terminated 1
Phase 11Completed 1

Follow PC-786: new trials by email Literature Review of PC-786 trials Research Report on PC-786

Trials (filtered) newest first · largest first

All 2 trials

Tick up to 5 trials to compare them side by side (eligibility, arms, endpoints, adverse events) in a Literature Matrix.

TrialPhaseStatusSponsorEnrollmentStartUpdated
Anti-viral Effect of PC786 on RSV Infection on HSCT Recipients
PC786, Placebo, SOC - Respiratory Syncytial Virus Infections
Phase 2TerminatedPulmocide Ltd52018-11-052019-06-12
A Study of PC786 to Evaluate the Antiviral Activity, Safety and Pharmacokinetics of Multiple Doses in an RSV Challenge Study
PC786, Placebo/vehicle - Respiratory Syncytial Virus Infections
Phase 1 / Phase 2CompletedPulmocide Ltd562017-11-142018-05-16

Conditions studied

Respiratory Syncytial Virus Infections (2)

Sponsors

Pulmocide Ltd (2)

Countries

United Kingdom (2)

Top investigators

Alison Murray (1)  ·  Bryan J Murray, MBBS (1)

Results publications

PMID 33216113

NIH funding

2017 (1), 2018 (1)